Fair Value Calculator Fair Value Calculator
EN DE

500124 (500124) Fair Value & Analysis

IN · Market cap ₹750B

5 500124 500124 · BSE
Price₹1,375
Fair Value₹1,822
Upside+32.6%
Quality53/100
Watch 500124 for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹960.36 – ₹2,562

Fair value as of: Jul 4, 2026

From 26 valuation models · updated 8 days ago

Share price +8.9% over the past month.

Price vs Fair Value (12 months)

₹1,376 ₹1,156 Fair Value ₹1,822 Jun 2025 Jul 2026

12‑month range ₹1,156 – ₹1,376 · fair‑value band ₹960.36 – ₹2,562 · the ₹1,375 price screens below the ₹1,822 fair value. As of Jul 4, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

500124 (500124) currently trades at ₹1,375, while our model-based Fair Value estimate is ₹1,822 — implying the stock looks roughly 32.6% undervalued today. We read business quality at 53/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

The stock trades on a trailing P/E of 31.7. Fundamentals as of Jul 4, 2026

Our scenario range runs from ₹960.36 (bear case) to ₹2,562 (bull case); at ₹1,375, the current price sits within that range. The share trades about 3% below its 52-week high and 20% above its 52-week low.

Key figures & financial health

Return on equity 1,114%
P/E ratio 31.7
EPS (TTM) ₹117.95

Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

500124 reported revenue of ₹326B in FY2024 versus ₹190B in FY2020, a compound +14.4%/yr. Reported net income was ₹56.6B in FY2024, compounding +30.5%/yr from FY2020.

Revenue +14.4%/yr
FY20 ₹190B
FY21 ₹215B
FY22 ₹247B
FY23 ₹280B
FY24 ₹326B
Net income +30.5%/yr
FY20 ₹19.5B
FY21 ₹21.8B
FY22 ₹45.1B
FY23 ₹55.8B
FY24 ₹56.6B

Is 500124 fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "500124 Fair Value". https://www.fairvalue-calculator.com/stock/500124

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 500124 (500124) undervalued?
As of Jul 4, 2026, our model estimates a fair value of ₹1,822 versus a price of ₹1,375 — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 500124?
Our model-based fair value for 500124 is ₹1,822 (as of Jul 4, 2026), built from audited fundamentals. The current price is ₹1,375.
What is the quality score of 500124?
500124 has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of 500124?
The net profit margin of 500124 is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

14 days Pro free · no card

Unlock the full 500124 analysis — and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.